Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis

被引:8
作者
Corma-Gomez, Anais [1 ]
Macias, Juan [1 ]
Ramon Lacalle-Remigio, Juan [2 ]
Tellez, Francisco [3 ]
Morano, Luis [4 ]
Rivero, Antonio [5 ]
Serrano, Miriam [6 ]
Jose Rios, Maria [7 ]
Jesus Vera-Mendez, Francisco [8 ]
Carlos Alados, Juan [9 ]
Miguel Real, Luis [10 ]
Palacios, Rosario [11 ]
De los Santos, Ignacio [12 ]
Imatz, Arkaitz [13 ]
Antonio Pineda, Juan [1 ]
机构
[1] Hosp Univ Valme, Unit Infect Dis & Microbiol, Seville, Spain
[2] Univ Seville, Fac Med, Div Prevent Med & Publ Hlth, Seville, Spain
[3] Hosp Univ Puerto Real, Fac Med, Unit Infect Dis, Cadiz, Spain
[4] Hosp Univ Alvaro Cunqueiro, Unit Infect Pathol, Vigo, Spain
[5] Hosp Univ Reina Sofia, Unit Infect Dis, Cordoba, Spain
[6] Hosp Univ Gran Canaria Dr Negrin, Unit Infect Dis, Las Palmas Gran Canaria, Spain
[7] Hosp Univ Virgen Macarena, Unit Infect Dis, Seville, Spain
[8] Hosp Gen Univ Santa Lucia, Sect Infect Med, Serv Internal Med, Cartagena, Spain
[9] Univ Hosp Jerez, Unit Clin Microbiol, Cadiz, Spain
[10] Univ Malaga, Fac Med, Unit Immunol Biochem Mol Biol & Surg, Malaga, Spain
[11] Hosp Virgen Victoria, Unit Infect Dis & Microbiol, Malaga, Spain
[12] Hosp La Princesa, Unit Internal Med & Infect Dis, Madrid, Spain
[13] Hosp Univ Bellvitge, Unit Infect Dis, Barcelona, Spain
关键词
HIV/HCV-coinfection; sustained virological response; direct-acting antivirals; hepatocellular carcinoma; liver decompensation; COINFECTED PATIENTS; LIVER-DISEASE; PROGRESSION; NUCLEOSIDE;
D O I
10.1093/cid/ciaa1111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The aim of this study was to assess the impact of human immunodeficiency virus (HIV) infection on the risk of developing hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV) who achieve sustained virological response (SVR) with direct-acting antiviral (DAA). Methods. Multisite prospective cohort study, where HCV-monoinfected patients and HIV/HCV-coinfected individuals were included if they met: (1) SVR with DAA-based combination; (2) liver stiffness (LS) >= 9.5 kPa previous to treatment; (3) LS measurement at the SVR time-point. The main endpoint was the occurrence of HCC. Propensity score (PS) was calculated to address potential confounders due to unbalanced distribution of baseline characteristics of HIV/HCV-coinfected and HCV-monoinfected patients. Results. In total, 1035 HCV-infected patients were included, 667 (64%) coinfected with HIV. After a median (Q1-Q3) follow-up time of 43 (31-49) months, 19 (1.8%) patients developed HCC (11 [3.0%]; HCV-monoinfected, 8[1.2%]; HIV/HCV-coinfected individuals; P = .013). In the multivariable analysis, HIV coinfection was associated with a lower adjusted risk of developing HCC (subhazard ratio [sHR] = 0.27, 95% confidence interval [CI]: .08-.90; P = .034). Predictors of HCC emergence were: HCV genotype 3 (sHR = 7.9, 95% CI: 2.5-24.9; P < .001), MELD score at SVR >10 (sHR = 1.37, 95% CI: 1.01-1.86; P = .043) and LS value at SVR (sHR = 1.03, 95% CI: 1.01-1.06, for 1 kPa increase; P = .011). Using inverse probability weighting method on the PS, HIV-infected patients had a lower risk of HCC (powered HR = 0.33, 95% CI: .11-.85). Conclusions. Among HCV-infected patients with advanced fibrosis, who achieve SVR with DAA, HIV coinfection seems to be associated with a lower risk of HCC occurrence. The underlying causes for this finding need to be investigated.
引用
收藏
页码:E2109 / E2116
页数:8
相关论文
共 34 条
  • [31] Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients
    Salmon-Ceron, Dominique
    Nahon, Pierre
    Layese, Richard
    Bourcier, Valerie
    Sogni, Philippe
    Bani-Sadr, Firouze
    Audureau, Etienne
    Merchadou, Laurence
    Dabis, Francois
    Wittkop, Linda
    Roudot-Thoraval, Francoise
    Nahon, P.
    Layese, R.
    Roudot-Thoraval, F.
    Bedossa, P.
    Bonjour, M.
    Bourcier, V.
    Dharancy, S.
    Durand-Zaleski, I.
    Fontaine, H.
    Guyader, D.
    Laurent, A.
    Leroy, V.
    Marche, P.
    Salmon, D.
    Thibault, V.
    Vilgrain, V.
    Zucman-Rossi, J.
    Cagnot, C.
    Petrov-Sanchez, V.
    Nahon, P.
    Bourcier, V.
    Pol, S.
    Fontaine, H.
    Benhamou, Y.
    Serfaty, L.
    Roulot, D.
    Marcellin, P.
    Mallat, A.
    Attali, P.
    Grange, J. D.
    Capron, D.
    Cales, P.
    Bourliere, M.
    Bronowicki, J. P.
    Tran, A.
    Mal, F.
    Christidis, C.
    Silvain, C.
    Guyader, D.
    [J]. HEPATOLOGY, 2019, 70 (03) : 939 - 954
  • [32] Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
    van der Meer, Adriaan J.
    Feld, Jordan J.
    Hofer, Harald
    Almasio, Piero L.
    Calvaruso, Vincenza
    Fernandez-Rodriguez, Conrado M.
    Aleman, Soo
    Ganne-Carrie, Nathalie
    D'Ambrosio, Roberta
    Pol, Stanislas
    Trapero-Marugan, Maria
    Maan, Raoel
    Moreno-Otero, Ricardo
    Mallet, Vincent
    Hultcrantz, Rolf
    Weiland, Ola
    Rutter, Karoline
    Di Marco, Vito
    Alonso, Sonia
    Bruno, Savino
    Colombo, Massimo
    de Knegt, Robert J.
    Veldt, Bart J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (03) : 485 - 493
  • [33] van der Wal WM, 2011, J STAT SOFTW, V43, P1
  • [34] Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Chan, Henry Lik-Yuen
    Tse, Yee-Kit
    Lui, Grace Chung-Yan
    Wong, Grace Lai-Hung
    [J]. GASTROENTEROLOGY, 2020, 158 (01) : 215 - +